Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer

Clinical Pharmacology and Therapeutics
K D Haegele, P J Schechter

Abstract

Six healthy men received single oral doses of 1500 mg of vigabatrin [(R,S)-gamma-vinyl-GABA] and 750 mg of S(+)-gamma-vinyl-GABA on two occasions. Concentrations of the individual enantiomers were assayed by a stereoselective procedure based on combined GC/MS. At peak, concentrations of the R(-)-enantiomer exceeded concentrations of the S(+)-enantiomer, with an approximate ratio of 2:1. The mean terminal t1/2 ranged from 6 to 8 hours for both enantiomers. Mean urinary recovery of the S(+)-enantiomer was 49% after both doses and was 65% for the R(-)-enantiomer. Plasma concentration values obtained for the S(+)-enantiomer after a dose of the pure S(+)-enantiomer and an equivalent dose of the racemate showed good agreement for both the concentrations observed at any time point and the elimination characteristics, demonstrating bioequivalence. Renal clearance values for the S(+)-enantiomer are not affected by concomitant dosing with the pharmacologically inactive R(-)-enantiomer. No chiral inversion was detected after dosing with the pure S(+)-enantiomer.

Citations

Apr 1, 1992·Pharmacology & Toxicology·A Sabers, L Gram
Jan 1, 1989·British Journal of Clinical Pharmacology·P J Schechter
Oct 13, 2000·Fundamental & Clinical Pharmacology·M S Benedetti
Dec 7, 2000·Mental Retardation and Developmental Disabilities Research Reviews·J M Pellock, L D Morton
Jan 24, 2002·Therapeutic Drug Monitoring·Houda HachadRene H Levy
Mar 3, 2011·Pharmacotherapy·Kimberly A PesaturoPaul Belliveau
Jun 11, 2011·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Juseop KangMin-Young Jun
Nov 9, 2011·Acta Neurologica Scandinavica. Supplementum·E Ben-Menachem
Jan 22, 2013·Paediatric Drugs·Linda G M van RooijLinda S de Vries
Aug 1, 1992·British Journal of Clinical Pharmacology·J C ChallierG Olive
Aug 1, 1994·Biopharmaceutics & Drug Disposition·D K YuS J Weir
Jan 1, 1995·Epilepsia·E Ben-Menachem
Nov 5, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jarogniew J LuszczkiStanislaw J Czuczwar
Jan 1, 1996·Epilepsia·L Gram
Aug 10, 1999·Biopharmaceutics & Drug Disposition·E ReyG Olive
Jul 14, 2018·Paediatric Drugs·Giulia IapadreAlberto Verrotti
Jan 12, 2000·The Annals of Pharmacotherapy·B E GidalJ T Gilman
Jan 1, 1989·British Journal of Clinical Pharmacology·M Frisk-HolmbergP Meyer
Oct 23, 2014·Therapeutic Delivery·Martha Kampp NøhrCarsten Uhd Nielsen
Dec 4, 2009·Expert Opinion on Pharmacotherapy·Justin A Tolman, Michele A Faulkner
May 13, 1998·British Journal of Clinical Pharmacology·A TranG Olive

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.